Education
About Us
Working with TipRanks
Follow Us
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Total Valuation
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has a market cap or net worth of HK$435.36B. The enterprise value is HK$316.83B.
Market CapHK$435.36B
Enterprise ValueHK$316.83B
Share Statistics
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has 258,197,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding258,197,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is 58.5. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s PEG ratio is ―.
PE Ratio58.5
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of 0.36%
Dividend Per Share―
Dividend Yield0.36%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change23.84%
50-Day Moving Average71.90
200-Day Moving Average―
Relative Strength Index (RSI)33.12
Average Volume (3m)3.62M
Important Dates
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateOct 24, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is HK$96.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$96.90
Price Target Upside46.82% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―